BI1206 clinical trials

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

This study is testing a new drug, BI-1206, with an existing cancer treatment, pembrolizumab, for adults with advanced solid tumours. It aims to find the safest dose and see if this combination can help people whose cancer has progressed or who haven't had previous treatment for advanced disease.